This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers | MicrobiomeTrials
← Back to trials NCT07811271
Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10Est. Completion: 2029-11-30
Enrollment target: 600 participantsOther microbiome trials you might be interested in Ovarian Cancer
This is a single site, open label, Phase 1 study using a 3 + 3 dose escalation design in two cohorts of adults with recu…
Palo Alto, United States Est. completion Jan 2027
Ovarian Cancer Genetic Testing Genetic Counseling
The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after vi…
Lexington, United States Est. completion Jul 2027
Recruiting
Sentinel Lymph Node Biopsy (SLNB) Early Stage Ovarian Tumors
the standard of care in case of early ovarian cancer (stage I or II) is a complete surgery. This surgery includes : hyst…
La Rabta, Tunisia Est. completion Dec 31, 2027